Muscarinic receptor oligomerization

Neuropharmacology

Volumn 136, Issue , 2018, Pages 401-410

  Marsango, Sara ^a   Ward, Richard J ^a   Alvarez Curto, Elisa ^a   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Dimerization; Ligand regulation; Muscarinic acetylcholine receptor; Oligomerization; Quaternary structure

Indexed keywords

CHAPERONE; G PROTEIN COUPLED RECEPTOR; MUSCARINIC RECEPTOR; PIRENZEPINE; TELENZEPINE;

BIOCHEMISTRY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOPHYSICS; ENDOPLASMIC RETICULUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; QUALITY CONTROL; RECEPTOR BINDING ASSAY; REVIEW; ANIMAL; DIMERIZATION; METABOLISM;

ANIMALS; DIMERIZATION; HUMANS; RECEPTORS, MUSCARINIC;

EID: 85034851232     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2017.11.023     Document Type: Review

References (99)

1. Alvarez-Curto, E., Ward, R.J., Pediani, J.D., Milligan, G., Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET. J. Biol. Chem. 285 (2010), 23318–23330, 10.1074/jbc.M110.122184.
2. Alvarez-Curto, E., Pediani, J.D., Milligan, G., Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Anal. Bioanal. Chem. 398 (2010), 167–180, 10.1007/s00216-010-3823-4.
3. Alvarez-Curto, E., Prihandoko, R., Tautermann, C.S., Zwier, J.M., Pediani, J.D., Lohse, M.J., Hoffmann, C., Tobin, A.B., Milligan, G., Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL). Mol. Pharmacol. 80 (2011), 1033–1046, 10.1124/mol.111.074674.
4. Alvarez-Curto, E., Inoue, A., Jenkins, L., Raihan, S.Z., Prihandoko, R., Tobin, A.B., Milligan, G., Targeted Elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G protein-coupled receptor signalling. J. Biol. Chem. 291 (2016), 27147–27159, 10.1074/jbc.M116.754887.
5. Aslanoglou, D., Alvarez-Curto, E., Marsango, S., Milligan, G., Distinct agonist regulation of muscarinic acetylcholine m2-m3 heteromers and their corresponding homomers. J. Biol. Chem. 290 (2015), 14785–14796, 10.1074/jbc.M115.649079.
6. Avissar, S., Amitai, G., Sokolovsky, M., Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. Proc. Natl. Acad. Sci. U. S. A. 80 (1983), 156–159.
7. Ayoub, M.A., Pfleger, K.D., Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr. Opin. Pharmacol. 10 (2010), 44–52, 10.1016/j.coph.2009.09.012.
8. Ayoub, M.A., Resonance energy transfer-based approaches to study GPCRs. Methods Cell Biol. 132 (2016), 255–292, 10.1016/bs.mcb.2015.10.008.
9. Barbeau, A., Godin, A.G., Swift, J.L., De Koninck, Y., Wiseman, P.W., Beaulieu, J.M., Quantification of receptor tyrosine kinase activation and transactivation by G-protein-coupled receptors using spatial intensity distribution analysis (SpIDA). Methods Enzymol. 522 (2013), 109–131, 10.1016/B978-0-12-408143-7.00001-3.
10. Berrie, C.P., Birdsall, N.J., Burgen, A.S., Hulme, E.C., Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem. Biophys. Res. Comm. 87 (1979), 1000–1005.
11. Birdsall, N.J., Burgen, A.S., Hulme, E.C., The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 14 (1978), 723–736.
12. Calebiro, D., Rieken, F., Wagner, J., Sungkaworn, T., Zabel, U., Borzi, A., Cocucci, E., Zürn, A., Lohse, M.J., Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc. Natl. Acad. Sci. U. S. A., 2013, 10.1073/pnas.1205798110 110,743–748.
13. Chabre, M., Cone, R., Saibil, H., Is rhodopsin dimeric in native retinal rods?. Nature 426 (2003), 30–31.
14. Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G., Thian, F.S., Kobilka, T.S., Choi, H.J., Kuhn, P., Weis, W.I., Kobilka, B.K., Stevens, R.C., High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007), 1258–1265.
15. Ciruela, F., Vilardaga, J.P., Fernández-Dueñas, V., Lighting up multiprotein complexes: lessons from GPCR oligomerization. Trends Biotechnol. 28 (2010), 407–415, 10.1016/j.tibtech.2010.05.002.
16. Conklin, B.R., Hsiao, E.C., Claeysen, S., Dumuis, A., Srinivasan, S., Forsayeth, J.R., Guettier, J.M., Chang, W.C., Pei, Y., McCarthy, K.D., Nissenson, R.A., Wess, J., Bockaert, J., Roth, B.L., Engineering GPCR signaling pathways with RASSLs. Nat. Methods 5 (2008), 673–678, 10.1038/nmeth.1232.
17. Dong, S., Rogan, S.C., Roth, B.L., Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs. Nat. Protoc 5 (2010), 561–573, 10.1038/nprot.2009.239.
18. Ehlert, F.J., The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol. Pharmacol. 28 (1985), 410–421.
19. Farran, B., An update on the physiological and therapeutic relevance of GPCR oligomers. Pharmacol. Res. 117 (2017), 303–327, 10.1016/j.phrs.2017.01.008.
20. Felce, J.H., Latty, S.L., Knox, R.G., Mattick, S.R., Lui, Y., Lee, S.F., Klenerman, D., Davis, S.J., Receptor quaternary organization explains G protein-coupled receptor family structure. Cell Rep. 20 (2017), 2654–2665, 10.1016/j.celrep.2017.08.072.
21. Ferré S., Casadó V., Devi, L.A., Filizola, M., Jockers, R., Lohse, M.J., Milligan, G., Pin, J.P., Guitart, X., G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol. Rev. 66 (2014), 413–434, 10.1124/pr.113.008052.
22. Fotiadis, D., Jastrzebska, B., Philippsen, A., Müller, D.J., Palczewski, K., Engel, A., Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. Curr. Opin. Struct. Biol. 16 (2006), 252–259.
23. Franco, R., Martinez-Pinilla, E., Lanciego, J.L., Navarro, G., Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerisation. Front. Pharmacol., 7, 2016, 76, 10.3389/fphar.2016.00076.
24. Gahbauer, S., Böckmann, R.A., Membrane-mediated oligomerisation of G protein coupled receptors and its implications for GPCR function. Front. Pharmacol., 7, 2016, 494, 10.3389/fphar.2016.00494.
25. Galper, J.B., Haigh, L.S., Hart, A.C., O'Hara, D.S., Livingston, D.J., Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane. Mol. Pharmacol. 32 (1987), 230–240.
26. Geng, Y., Mosyak, L., Kurinov, I., Zuo, H., Sturchler, E., Cheng, T.C., Subramanyam, P., Brown, A.P., Brennan, S.C., Mun, H., Bush, M., Chen, Y., Nguyen, T.X., Cao, B., Chang, D.D., Quick, M., Conigrave, A.D., Colecraft, H.M., McDonald, P., Fan, Q.R., Structural mechanism of a ligand activation in human calcium-sensing receptor. Elife, 5, 2016, 10.7554/eLife.13662 pii: e13662.
27. Godin, A.G., Costantino, S., Lorenzo, L.E., Swift, J.L., Sergeev, M., Ribeiro-da-Silva, A., De Koninck, Y., Wiseman, P.W., Revealing protein oligomerization and densities in situ using spatial intensity distribution analysis. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 7010–7015, 10.1073/pnas.1018658108.
28. Godin, A.G., Rappaz, B., Potvin-Trottier, L., Kennedy, T.E., De Koninck, Y., Wiseman, P.W., Spatial Intensity Distribution Analysis reveals abnormal oligomerization of proteins in single cells. Biophys. J. 109 (2015), 710–721, 10.1016/j.bpj.2015.06.068.
29. Goin, J.C., Nathanson, N.M., Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization. J. Biol. Chem. 281 (2006), 5416–5425.
30. Gupta, K., Donlan, J.A.C., Hopper, J.T.S., Uzdavinys, P., Landreh, M., Struwe, W.B., Drew, D., Baldwin, A.B., Stansfeld, P.J., Robinson, C.V., The role of interfacial lipids in stabilizing membrane protein oligomers. Nature 541 (2017), 421–424, 10.1038/nature20820.
31. Haga, K., Kruse, A.C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W.I., Okada, T., Kobilka, B.K., Haga, T., Kobayashi, T., Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 482 (2012), 547–551, 10.1038/nature10753.
32. Hern, J.A., Baig, A.H., Mashanov, G.I., Birdsall, B., Corrie, J.E.T., Lazareno, S., Molloy, J.E., Birdsall, N.J.M., Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 2693–2698, 10.1073/pnas.0907915107.
33. Herrick-Davis, K., Grinde, E., Cowan, A., Mazurkiewicz, J.E., Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle. Mol. Pharmacol. 84 (2013), 630–642, 10.1124/mol.113.087072.
34. Hirschberg, B.T., Schimerlik, M.I., A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J. Biol. Chem. 269 (1994), 26127–26135.
35. Hoffmann, C., Gaietta, G., Zürn, A., Adams, S.R., Terrillon, S., Ellisman, M.H., Tsien, R.Y., Lohse, M.J., Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat. Protoc. 5 (2010), 1666–1677, 10.1038/nprot.2010.129.
36. 3 muscarinic acetylcholine receptor dimer formation and activation. FASEB J. 26 (2012), 604–616, 10.1096/fj.11-191510.
37. Hu, J., Hu, K., Liu, T., Stern, M.K., Mistry, R., Challiss, R.A., Costanzi, S., Wess, J., Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation. J. Biol. Chem. 288 (2013), 34777–34790, 10.1074/jbc.M113.503714.
38. Huang, J., Chen, S., Zhang, J.J., Huang, X.Y., Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state. Nat. Struct. Mol. Biol. 20 (2013), 419–425, 10.1038/nsmb.2504.
39. Hussain, A.F., Amoury, M., Barth, S., SNAP-tag technology: a powerful tool for site specific conjugation of therapeutic and imaging agents. Curr. Pharm. Des. 19 (2013), 5437–5442.
40. Ilien, B., Glasser, N., Clamme, J.P., Didier, P., Piemont, E., Chinnappan, R., Daval, S.B., Galzi, J.L., Mely, Y., Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process. J. Biol. Chem. 284 (2009), 19533–19543, 10.1074/jbc.M109.017145.
41. Jaakola, V.P., Griffith, M.T., Hanson, M.A., Cherezov, V., Chien, E.Y., Lane, J.R., Ijzerman, A.P., Stevens, R.C., The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322 (2008), 1211–1217, 10.1126/science.1164772.
42. Jordan, B.A., Devi, L.A., G-protein-coupled receptor heterodimerisation modulates receptor function. Nature 399 (1999), 697–700.
43. Kniazeff, J., Prézeau, L., Rondard, P., Pin, J.P., Goudet, C., Dimers and beyond: the functional puzzles of class C GPCRs. Pharmacol. Ther. 130 (2011), 9–25, 10.1016/j.pharmthera.2011.01.006.
44. Kolberg, K., Puettmann, C., Pardo, A., Fitting, J., Barth, S., SNAP-tag technology: a general introduction. Curr. Pharm. Des. 19 (2013), 5406–5413.
45. Kruse, A.C., Hu, J., Pan, A.C., Arlow, D.H., Rosenbaum, D.M., Rosemond, E., Green, H.F., Liu, T., Chae, P.S., Dror, R.O., Shaw, D.E., Weis, W.I., Wess, J., Kobilka, B.K., Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482 (2012), 552–556, 10.1038/nature10867.
46. Kruse, A.C., Kobilka, B.K., Gautam, D., Sexton, P.M., Christopoulos, A., Wess, J., Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat. Rev. Drug Discov. 13 (2014), 549–560, 10.1038/nrd4295.
47. Kuner, R., Köhr, G., Grünewald, S., Eisenhardt, G., Bach, A., Kornau, H.C., Role of heteromer formation in GABAB receptor function. Science 283 (1999), 74–77.
48. Kuzak, A.J., Pitchiaya, S., Anand, J.P., Mosberg, H.I., Walter, N.G., Sunahara, R.K., Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J. Biol. Chem. 284 (2009), 26732–26741, 10.1074/jbc.M109.026922.
49. Lane, J.R., Canals, M., Sequential conformational rearrangements dictate the dynamics of class C GPCR activation. Sci. Signal., 5, 2012, pe51, 10.1126/scisignal.2003503.
50. Liang, Y., Fotiadis, D., Filipek, S., Saperstein, D.A., Palczewski, K., Engel, A., Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278 (2003), 21655–21662.
51. Liste, M.J., Caltabiano, G., Ward, R.J., Alvarez-Curto, E., Marsango, S., Milligan, G., The molecular basis of oligomeric organization of the human M3 muscarinic acetylcholine receptor. Mol. Pharmacol. 87 (2015), 936–953, 10.1124/mol.114.096925.
52. Maggio, R., Vogel, Z., Wess, J., Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular “cross-talk” between G-protein-linked receptors. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 3103–3107.
53. Maggio, R., Barbier, P., Fornai, F., Corsini, G.U., Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J. Biol. Chem. 271 (1996), 31055–31060.
54. Maggio, R., Barbier, P., Colelli, A., Salvadori, F., Demontis, G., Corsini, G.U., G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J. Pharmacol. Exp. Ther. 291 (1999), 251–257.
55. Manglik, A., Kruse, A.C., Kobilka, T.S., Thian, F.S., Mathiesen, J.M., Sunahara, R.K., Pardo, L., Weis, W.I., Kobilka, B.K., Granier, S., Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 485 (2012), 321–326, 10.1038/nature10954.
56. Margeta-Mitrovic, M., Jan, Y.N., Jan, L.Y., A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27 (2000), 97–106.
57. Marquer, C., Fruchart-Gaillard, C., Mourier, G., Grandjean, O., Girard, E., le Maire, M., Brown, S., Servent, D., Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor. Biol. Cell. 102 (2010), 409–420, 10.1042/BC20090171.
58. Marsango, S., Caltabiano, G., Pou, C., Liste, M.J., Milligan, G., Analysis of human dopamine D3 receptor quaternary structure. J. Biol. Chem. 290 (2015), 15146–15162, 10.1074/jbc.M114.630681.
59. Marsango, S., Varela, M.J., Milligan, G., Approaches to characterize and quantify oligomerization of GPCRs. Methods Mol. Biol. 1335 (2015), 95–105, 10.1007/978-1-4939-2914-6_7.
60. 3 receptor quaternary organization. Sci. Rep., 2017 (Accepted for publication).
61. Mattera, R., Pitts, B.J., Entman, M.L., Birnbaumer, L., Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. J. Biol. Chem. 260 (1985), 7410–7421.
62. Maurel, D., Comps-Agrar, L., Brock, C., Rives, M.L., Bourrier, E., Ayoub, M.A., Bazin, H., Tinel, N., Durroux, T., Prézeau, L., Trinquet, E., Pin, J.P., Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 5 (2008), 561–567, 10.1038/nmeth.1213.
63. McMillin, S.M., Heusel, M., Liu, T., Costanzi, S., Wess, J., Structural basis of M3 muscarinic receptor dimer/oligomer formation. J. Biol. Chem. 286 (2011), 28584–28598, 10.1007/978-1-4939-2914-6_7.
64. Miao, Y., Goldfeld, D.A., Von Moo, E., Sexton, P.M., Christopoulos, A., McCammon, J.A., Valant, C., Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E5675–E5684, 10.1073/pnas.1612353113.
65. Milligan, G., G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharm. 66 (2004), 1–7.
66. Milligan, G., G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br. J. Pharmacol. 158 (2009), 5–14, 10.1111/j.1476-5381.2009.00169.
67. Milligan, G., The prevalence, maintenance and relevance of G protein-coupled receptor oligomerisation. Mol. Pharm. 84 (2013), 158–169, 10.1124/mol.113.084780.
68. s. BMC Biol., 14, 2016, 26, 10.1186/s12915-016-0247-4.
69. 2 muscarinic acetylcholine receptors in live cardiac muscle. J. Mol. Cell Cardiol. 57 (2013), 129–136, 10.1016/j.yjmcc.2013.01.009.
70. Ng, G.Y., Clark, J., Coulombe, N., Ethier, N., Hebert, T.E., Sullivan, R., Kargman, S., Chateauneuf, A., Tsukamoto, N., McDonald, T., Whiting, P., Mezey, E., Johnson, M.P., Liu, Q., Kolakowski, L.F. Jr., Evans, J.F., Bonner, T.I., O'Neill, G.P., Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J. Biol. Chem. 274 (1999), 7607–7610.
71. Ng, G.Y., Bertrand, S., Sullivan, R., Ethier, N., Wang, J., Yergey, J., Belley, M., Trimble, L., Bateman, K., Alder, L., Smith, A., McKernan, R., Metters, K., O'Neill, G.P., Lacaille, J.C., Hébert, T.E., Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol. 59 (2001), 144–152.
72. Patowary, S., Alvarez-Curto, E., Xu, T.R., Holz, J.D., Oliver, J.A., Milligan, G., Raicu, V., The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane. Biochem. J. 452 (2013), 303–312, 10.1042/BJ20121902.
73. Park, P.S., Wells, J.W., Oligomeric potential of the M2 muscarinic cholinergic receptor. J. Neurochem. 90 (2004), 537–548.
74. Pediani, J.D., Ward, R.J., Godin, A.G., Marsango, S., Milligan, G., Dynamic regulation of quaternary organization of the M1 muscarinic receptor by subtype-selective antagonist drugs. J. Biol. Chem. 291 (2016), 13132–13146, 10.1074/jbc.M115.712562.
75. Pediani, J.D., Ward, R.J., Marsango, S., Milligan, G., Spatial intensity distribution analysis: studies of G Protein-coupled receptor oligomerisation. Trends Pharmacol. Sci. 1465 (2017), 30180–30183, 10.1016/j.tips.2017.09.001.
76. Pei, Y., Rogan, S.C., Yan, F., Roth, B.L., Engineered GPCRs as tools to modulate signal transduction. Physiol. (Bethesda). 23 (2008), 313–321, 10.1152/physiol.00025.2008.
77. Pisterzi, L.F., Jansma, D.B., Georgiou, J., Woodside, M.J., Chou, J.T., Angers, S., Raicu, V., Wells, J.W., Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. J. Biol. Chem. 285 (2010), 16723–16738, 10.1074/jbc.M109.069443.
78. Potter, L.T., Ballesteros, L.A., Bichajian, L.H., Ferrendelli, C.A., Fisher, A., Hanchett, H.E., Zhang, R., Evidence of paired M2 muscarinic receptors. Mol. Pharmacol. 39 (1991), 211–221.
79. Rasmussen, S.G., DeVree, B.T., Zou, Y., Kruse, A.C., Chung, K.Y., Kobilka, T.S., Thian, F.S., Chae, P.S., Pardon, E., Calinski, D., Mathiesen, J.M., Shah, S.T., Lyons, J.A., Caffrey, M., Gellman, S.H., Steyaert, J., Skiniotis, G., Weis, W.I., Sunahara, R.K., Kobilka, B.K., Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 477 (2011), 549–555, 10.1038/nature10361.
80. Redka, D.S., Heerklotz, H., Wells, J.W., Efficacy as an intrinsic property of the M(2) muscarinic receptor in its tetrameric state. Biochemistry 52 (2013), 7405–7427, 10.1021/bi4003869.
81. Redka, D.S., Morizumi, T., Elmslie, G., Paranthaman, P., Shivnaraine, R.V., Ellis, J., Ernst, O.P., Wells, J.W., Coupling of g proteins to reconstituted monomers and tetramers of the M2 muscarinic receptor. J. Biol. Chem. 289 (2014), 24347–24365, 10.1074/jbc.M114.559294.
82. Shivnaraine, R.V., Fernandes, D.D., Ji, H., Li, Y., Kelly, B., Zhang, Z., Han, Y.R., Huang, F., Sankar, K.S., Dubins, D.N., Rocheleau, J.V., Wells, J.W., Gradinaru, C.C., Single-molecule analysis of the supramolecular organization of the M2 muscarinic receptor and the Gαi1 protein. J. Am. Chem. Soc 138 (2016), 11583–11598, 10.1021/jacs.6b04032.
83. Shivnaraine, R.V., Kelly, B., Sankar, K.S., Redka, D.S., Han, Y.R., Huang, F., Elmslie, G., Pinto, D., Li, Y., Rocheleau, J.V., Gradinaru, C.C., Ellis, J., Wells, J.W., Allosteric modulation in monomers and oligomers of a G protein-coupled receptor. Elife, 6, 2016, 5, 10.7554/eLife.11685 pii: e11685.
84. Smith, N.J., Milligan, G., Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol. Rev. 62 (2010), 701–725, 10.1124/pr.110.002667.
85. Sposini, S., Caltabiano, G., Hanyaloglu, A.C., Miele, R., Identification of transmembrane domains that regulate spatial arrangements and activity of prokineticin receptor 2 dimers. Mol. Cell. Endocrinol. 399 (2015), 362–372, 10.1016/j.mce.2014.10.024.
86. Suda, K., Filipek, S., Palczewski, K., Engel, A., Fotiadis, D., The supramolecular structure of the GPCR rhodopsin in solution and native disc membranes. Mol. Membr. Biol. 21 (2004), 435–446.
87. 1 angiotension receptor homodimer: role of the conserved DRY motif. Biochem. Pharma. 84 (2012), 477–485, 10.1016/j.bcp.2012.04.014.
88. Tabor, A., Weisenburger, S., Banerjee, A., Purkayastha, N., Kaindl, J.M., Hübner, H., Wei, L., Grömer, T.W., Kornhuber, J., Tschammer, N., Birdsall, N.J., Mashanov, G.I., Sandoghdar, V., Gmeiner, P., Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level. Sci. Rep., 6, 2016, 33233, 10.1038/srep33233.
89. Thal, D.M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C.C., Bures, M.G., Evans, D.A., Weis, W.I., Bachhawat, P., Kobilka, T.S., Sexton, P.M., Kobilka, B.K., Christopoulos, A., Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature 531 (2016), 335–340, 10.1038/nature17188.
90. Vafabakhsh, R., Levitz, J., Isacoff, E.Y., Conformational dynamics of a class C G-protein-coupled receptor. Nature 524 (2015), 497–501, 10.1038/nature14679.
91. Wacker, D., Wang, C., Katritch, V., Han, G.W., Huang, X.P., Vardy, E., McCorvy, J.D., Jiang, Y., Chu, M., Siu, F.Y., Liu, W., Xu, H.E., Cherezov, V., Roth, B.L., Stevens, R.C., Structural features for functional selectivity at serotonin receptors. Science 340 (2013), 615–619, 10.1126/science.1232808.
92. 1 receptors assessed via N-terminal SNAP and CLIP-tagging. Brt. J. Pharm. 162 (2010), 1439–1452, 10.1111/j.1476-5381.2010.01156.
93. Ward, R.J., Pediani, J.D., Godin, A.G., Milligan, G., Regulation of oligomeric organization of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor observed by spatial intensity distribution analysis. J. Biol. Chem. 290 (2015), 12844–12857, 10.1074/jbc.M115.644724.
94. Ward, R.J., Pediani, J.D., Harikumar, K.G., Miller, L.J., Milligan, G., Spatial Intensity Distribution Analysis quantifies the extent and regulation of homo-dimerization of the secretin receptor. Biochem. J. 474 (2017), 1879–1895, 10.1042/BCJ20170184.
95. Whorton, M.R., Bokoch, M.P., Rasmussen, S.G.F., Huang, B., Zare, R.N., Kobilka, B., Sunahara, R.K., A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 7682–7687.
96. Wreggett, K.A., Wells, J.W., Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem. 270 (1995), 22488–22499.
97. Zakrys, L., Ward, R.J., Pediani, J.D., Godin, A.G., Graham, G.J., Milligan, G., Roundabout 1 exists predominantly as a basal dimeric complex and this is unaffected by binding of the ligand Slit2. Biochem. J. 461 (2014), 61–73, 10.1042/BJ20140190.
98. Zeng, F.Y., Wess, J., Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274 (1999), 19487–19497.
99. Zhang, K., Zhang, J., Gao, Z.G., Zhang, D., Zhu, L., Han, G.W., Moss, S.M., Paoletta, S., Kiselev, E., Lu, W., Fenalti, G., Zhang, W., Müller, C.E., Yang, H., Jiang, H., Cherezov, V., Katritch, V., Jacobson, K.A., Stevens, R.C., Wu, B., Zhao, Q., Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509 (2014), 115–118, 10.1038/nature13083.